Wellcome Trust’s Medline Inc MDLN Stock Holding History

Wellcome Trust’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-146,602	Closed	-$6.52M	–	21
2026 Q1	$6.52M	Buy	+146,602	New	+$6.47M	0.08%	20

Other funds holding MDLN

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Essential Investment Partners LLC Englewood, Colorado $125M AUM

Wellcome Trust's MDLN Position: Q2 2026 in Review

Wellcome Trust sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 146,602 shares — an estimated $6.52M sold.

Wellcome Trust first reported a position in MDLN in Q1 2026 and held it in 1 quarter. The position peaked at $6.52M in Q1 2026. 21 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Wellcome Trust reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
Wellcome Trust sold 146,602 Medline Inc shares in Q2 2026, an estimated $6.52M.
Wellcome Trust first reported a position in Medline Inc in Q1 2026 and held it in 1 quarter.
Wellcome Trust's Medline Inc position peaked at $6.52M in Q1 2026.
21 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Wellcome Trust's 13F filing for Q2 2026, filed 9 Jul 2026.